Barry P. Flannelly

Barry P. Flannelly filed 98 disclosures between January 8, 2016 and July 17, 2025, 95 of them at Incyte Corp, under the title EVP & General Manager US, and 3 at Genomic Health Inc, as a Director. No purchase appears.

The 34 sales total EUR 14,580,475, with a median of EUR 126,628. Three stand out: EUR 2,106,670 on October 7, 2016, EUR 1,650,491 on April 8, 2022 and EUR 1,567,472 on April 8, 2022. The rest of the record holds 48 share grants, 15 option exercises and one filing of another kind.

The yearly pace shows a clear peak: 21 filings in 2019 and 15 in 2020, against 3 to 13 in the other years. No filing falls in the last twelve months. They are published a median of 2 days after the trade.

Within 30 days of colleagues at Incyte Corp, Flannelly has 15, 13 and 12 own market trades, in that order, all on the same side. The colleagues, in the same order: Vijay K. Iyengar, Paul Trower and Paula J. Swain.